Close Menu

skin cancer

Researchers from the Sanger Institute used genomic sequencing to study how somatic mutations build up prior to becoming cancerous. 

A new genome-wide association study used imputation to test millions of variants in basal cell carcinoma cases and controls from Iceland.

NEW YORK (GenomeWeb News) – Verisante Technology said this week that it has begun submitting an application to the US Food and Drug Administration for 510(k) clearance of its Aura skin cancer detection device.

NEW YORK (GenomeWeb) – EKF Diagnostics Holdings today said it and Massachusetts General Hospital have entered into a two-year research collaboration to develop EFK's PointMan assays for certain cancers.

NEW YORK (GenomeWeb) – Biocartis today announced it has obtained CE-IVD marking for and commercially launched the Idylla molecular diagnostics platform and BRAF Mutation Test.

NEW YORK (GenomeWeb News) – Verisante Technology last week posted a sharp drop in Q1 2014 revenues, as the firm terminated its Canadian distributor agreement for its Raman spectroscopy-based Aura skin cancer detection device, choosing instead to pursue a direct sales approach.

NEW YORK (GenomeWeb) – Melanoma test development firm DermTech International has filed to go public with a proposed offering of up to $25 million in stock.

Verisante Technology last week reported second quarter revenues of C$178,000 ($170,000), all from sales of its Aura skin cancer detection device.

Verisante Technology said this week it has signed an exclusive distribution deal with Pacifica Handels to distribute its Aura skin cancer detection device in Switzerland.

Verisante Technology said this week that it has received the first orders for its Raman spectroscopy-based Aura skin cancer detection system and plans an initial production run of 10 devices to be placed in Canada and Europe.

Pages

The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.

The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.

New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.

In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.